Novel use of ultrasound-guided endo-cavitary probe to evaluate an impalpable parapharyngeal mass

2009 ◽  
Vol 124 (3) ◽  
pp. 328-329 ◽  
Author(s):  
A Riskalla ◽  
A Arora ◽  
F Vaz ◽  
P O'Flynn

AbstractAim:We present a novel, previously undescribed technique of obtaining a biopsy from an inaccessible parapharyngeal space mass.Method:A modified endo-cavitary ultrasound probe was utilised to obtain an intra-oral, image-guided core biopsy of a parapharyngeal tumour. The parapharyngeal mass was not accessible to percutaneous ultrasound-guided biopsy due to its anatomical location.Conclusion:To our knowledge, this is the first such modification of the conventional endo-cavitary probe technique described in the literature. The technique permits accurate, well controlled biopsy of lesions located high in the parapharyngeal space, under general anaesthesia.

2007 ◽  
Vol 65 (5) ◽  
pp. AB199
Author(s):  
Daniel Sussman ◽  
Carmen R. Gomez-Fernandez ◽  
Afonso C. Ribeiro

Author(s):  
Philip A. Di Carlo

Prior to 1993, when ultrasound-guided core breast biopsy was first described by Parker and colleagues, surgery following image-guided needle localization was necessary to obtain a histological diagnosis of breast lesions. But there are many financial, practical, and clinical advantages of image-guided core biopsy over surgical excisional biopsy. There are also many advantages to ultrasound-guided biopsy over stereotactic- or MRI-guided biopsy, detailed in this chapter. Ultrasound is now usually the modality of choice by which to perform core biopsies if the lesion is visualized by multiple imaging modalities. This chapter, appearing in the section on interventions and surgical changes, reviews the key points of performing ultrasound-guided core biopsy. Topics discussed include protocols for both spring-loaded and vacuum-assisted devices; pre-procedure and post-procedure management, and imaging follow-up.


2014 ◽  
Vol 94 (3) ◽  
pp. 319-325 ◽  
Author(s):  
Sascha Kaufmann ◽  
Stephan Kruck ◽  
Ulrich Kramer ◽  
Sergios Gatidis ◽  
Arnulf Stenzl ◽  
...  

Objective: To directly compare the diagnostic performance of targeted MRI-guided biopsy (MR-GB) and systematic transrectal ultrasound-guided biopsy (TRUS-GB). Methods: Thirty-five patients with at least one negative TRUS-GB, persistently elevated or rising prostate-specific antigen and a lesion suspicious for prostate cancer (PC) on multiparametric MRI (mpMRI) scored by using the Prostate Imaging Reporting and Data System (PI-RADS) were included. A median of three targeted biopsies per lesion were obtained and systematic TRUS-GB was performed subsequently by an independent urologist without knowledge of the MRI findings. Definite pathology reports were analyzed for anatomical location and criteria of clinical significance. Results: The tumor detection rate was significantly higher with MR-GB compared with TRUS-GB (16/35, 46% and 8/35, 23%, respectively, p < 0.05). MR-GB detected PC in all patients with positive TRUS-GB. All tumors detected by MR-GB exhibited at least one criterion of clinical significance. PC lesions showed a significantly higher PI-RADS sum score compared with benign lesions. Conclusions: MR-GB is more effective compared with TRUS-GB in detecting clinically significant PC in men after previous negative TRUS-GB. PI-RADS scores give additional information and could be part of the decision-making process when considering retrial biopsy. Additional systematic biopsy can be omitted in patients undergoing targeted MR-GB.


2019 ◽  
Author(s):  
I Pita ◽  
J Fernandes ◽  
P Pimentel-Nunes ◽  
P Monteiro ◽  
M Dinis-Ribeiro ◽  
...  

2001 ◽  
Vol 44 (2) ◽  
pp. 161
Author(s):  
Jong An Kim ◽  
Sun Su Kim ◽  
Young Seok Seon ◽  
Kyoung Rok Lee ◽  
Byoung Geun Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document